Results 231 to 240 of about 68,398 (251)

Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages

Clinical and Experimental Immunology, 2016
Thomas Witzig, G S Nowakowski
exaly  

An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab

Molecular Immunology, 2012
Steven Sherwood
exaly  

ANTI-CD20 MONOCLONAL ANTIBODIES

2009
UCHIYAMA SUSUMU, FUKUI KIICHI
openaire   +1 more source

ANTI-CD20 MONOCLONAL ANTIBODY

2007
UCHIYAMA SUSUMU, FUKUI KIICHI
openaire   +1 more source

A phase 1/2 trial of ublituximab, a novel anti‐ CD 20 monoclonal antibody, in patients with B‐cell non‐Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab

British Journal of Haematology, 2017
Changchun Deng, , Ahmed Sawas
exaly  

NEW HUMANIZED ANTI-CD20 MONOCLONAL ANTIBODY

2011
LIU JIE, ZHANG YONGKE
openaire   +4 more sources

Treatment of refractory pemphigus vulgaris with anti‐CD20 monoclonal antibody (rituximab): Five cases

Journal of Dermatological Treatment, 2007
exaly  

[Monoclonal anti-CD20 antibody therapy].

La Revue du praticien, 2004
Laurence, Juhel, Philippe, Solal-Celigny
openaire   +1 more source

A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody

Annals of Hematology, 2003
Jean-Henri Bourhis, Bourhis Jean-Henri
exaly  

A Review of Rituximab, the First Anti-CD20 Monoclonal Antibody used in the Treatment of B Non-Hodgkin’s Lymphomas

Future Oncology, 2015
exaly